The promise it holds for AFP surveillance and the possibility for its use in surveillance of other diseases necessitates its study on a larger scale to get a better idea of its impact on a sample more representative of the Nigerian AFP surveillance system, as well as that of other polio high risk countries. This evidence concerns the gene AFP and poliomyelitis.